These 2020 Medtech Predictions Were Surprisingly Accurate — for the Wrong Reasons
COVID-19 threw a gargantuan curveball at medtech, but these industry predictions for 2020 have been surprisingly on point, so far. See what we got right and what we didn't.
August 11, 2020
Never has the phrase, "hindsight is 20-20" been more applicable than in the year 2020. Now that we're more than halfway through this wildly unprecedented year, we thought it would be interesting to look back at these 2020 medtech predictions to see just how far off the mark we were.
To our surprise, most of the predictions have actually been spot on, albeit for very different reasons than we expected.
Digital Health
Ralph Hugeneck, senior director of technology at Nypro, could not have been more correct when he told MD+DI Editor-in-Chief Daphne Allen that 2020 would be a big year for digital health.
“In recent months, we’ve seen big changes in reimbursement strategies that will influence this trend," Hugeneck said. "For example, physicians are now reimbursed for working with connected care platforms. There is a huge demand in getting data from patients, whether regarding clinical trials or the everyday life of the patient, which requires a significant amount of integration—sensors that capture data, additional components in constrained space, movement in the diagnostics space to microfluidics for DNA sampling and processing.”
While all of those factors have certainly played a role in preparing the healthcare industry at large for the digital health explosion that we've seen in the past six months, COVID-19 is what really fueled the rapid growth and adoption of digital health technologies such as telemedicine